Indication
Complicated Intra-Abdominal Infection
1 clinical trial
3 products
Clinical trial
A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem in Pediatric Subjects With Complicated Intra-Abdominal InfectionStatus: Completed, Estimated PCD: 2020-03-16
Product
MetronidazoleProduct
MeropenemProduct
Ceftolozane/Tazobactam